LETROZOLE (Jiangsu Hengrui Medicine Co., Ltd.)
Welcome to the PulseAid listing for the LETROZOLE drug offered from Jiangsu Hengrui Medicine Co., Ltd.. This Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Jiangsu Hengrui Medicine Co., Ltd. |
NON-PROPRIETARY NAME: | LETROZOLE |
SUBSTANCE NAME: | LETROZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-05-16 |
END MARKETING DATE: | 0000-00-00 |
LETROZOLE HUMAN PRESCRIPTION DRUG Details:
Item Description | LETROZOLE from Jiangsu Hengrui Medicine Co., Ltd. |
LABELER NAME: | Jiangsu Hengrui Medicine Co., Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2013-05-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57884-2021_5b5bbc77-9bde-4c21-e053-2991aa0a8135 |
PRODUCT NDC: | 57884-2021 |
APPLICATION NUMBER: | ANDA202716 |
Other LETROZOLE Pharmaceutical Manufacturers / Labelers: